About the Company
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $GILD News
Gilead's Aggressive Push Beyond HIV Treatments - Plans To Increase Cancer-Focused CAR-T Treatment Production
Gilead Sciences Inc’s (NASDAQ:GILD) executive revealed the company’s plans to increase its production of cell therapy cancer ...
Gilead Sciences Inc's Dividend Analysis
Gilead Sciences Inc (NASDAQ:GILD) recently announced a dividend of $0.77 per share, payable on 2024-03-28, with the ...
Here is What to Know Beyond Why Gilead Sciences, Inc. (GILD) is a Trending Stock
Gilead Sciences (GILD) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in ...
Gilead Sciences’ Growth Prospects Bolstered by Cell Therapy Segment and Strategic Expansion
J.P. Morgan analyst Chris Schott has maintained their bullish stance on GILD stock, giving a Buy rating on March 13. Chris Schott has given ...
Gilead and Merus Announce Collaboration to Discover Novel Antibody-Based Trispecific T-Cell Engagers
Gilead Sciences, Inc. (Nasdaq:GILD) and Merus N.V. (Nasdaq:MRUS) today announced a research collaboration, option and license ...
Gilead Sciences Inc GILD
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Gilead Sciences Announces Expiration of Hart-Scott-Rodino Waiting Period for CymaBay Tender Offer
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) with respect to Gilead’s ...
Gilead Sciences unveils campaign to help women fight cancer
Gilead Sciences, a research-based biopharmaceutical company from California, launched a women's health advocacy campaign in ...
Gilead Sciences Inc GILD
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Gilead Sciences Announces Expiration Of HSR Waiting Period For CymaBay Tender Offer
Gilead Sciences, Inc. (GILD) said the required waiting period under the HSR Act with respect to cash tender offer for CymaBay ...
Gilead Sciences, Merus collaborate to discover novel antibody-based trispecific T-cell engagers
Gilead Sciences, Inc. and Merus N.V. have announced a research collaboration, option and license agreement to discover novel ...
Loading the latest forecasts...